TSHA (Taysha Corp) Operatsion marja

Ommaviy kompaniya Taysha (TSHA) logotipi

Operatsion foyda marjasi Rett sindromi terapiyasi bo'yicha ijobiy ma'lumotlarning ta'sirini aks ettiradi, bunda -2998.00 belgisi joriy ko'rsatkich vazifasini o'taydi. Taysha Gene Therapies (TSHA) yagona asosiy dori vositasiga yo'naltirilgan boshqaruvni qayta tashkil etish orqali biznes samaradorligini ta'minlaydi. Taysha Gene Therapies (TSHA) kompaniyasining raqobatlashish qobiliyati maqsadli gen yetkazib berish tizimlari va kam uchraydigan kasalliklar dori vositalari uchun soliq imtiyozlariga asoslangan bo'lib, bu asab tizimi patologiyalarini davolashda vaqtincha monopoliyani kafolatlaydi.

TSHA: Taysha Gene Therapies, Inc. Sotuvning operatsion rentabelligi 04.07.2022 - 20.11.2026

tayshagtx.com (TSHA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning jamlanma tahliliyoti:Taysha Corp, TSHA
Taysha Gene Therapies tayyor mahsulotlari

Kapitalni bozor tebranishlaridan himoya qilish biznesning ichki samaradorligini chuqur tushunishni talab qiladi. Taysha Gene Therapies (TSHA) ning kam uchraydigan markaziy nerv tizimi patologiyalarini davolovchi pediatriya klinikalari bilan hamkorligi kelgusidagi monetizatsiya uchun asos bo'ladi. EBIT marjasini tahlil qilish orqali investor moliyaviy xarajatlargacha bo'lgan tushumda operatsion foydaning ulushini baholaydi. Ushbu ko'rsatkich kompaniyaning o'z asosiy faoliyatidan pul oqimini yaratish qobiliyatini o'lchaydi. Ushbu metrikaning barqarorligi portfelning uzoq muddatli chidamliligini belgilaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik